[Table/Fig-3]:
Various studies from India showing prevalence of clindamycin resistance in Staphylococcus aureus isolates
| Author’s name | MRSA | MSSA | ||||
|---|---|---|---|---|---|---|
| iMLSB phenotype (%) |
cMLSB phenotype (%) |
MS Phenotype (%) |
iMLSB phenotype (%) |
cMLSB phenotype (%) |
MS Phenotype (%) |
|
| Gadepalli et al., [4] | 30 | 38 | 12 | 10 | 15 | 12 |
| Gupta et al., [17] | 20 | 46 | 16 | 17.3 | 10 | 37.3 |
| Deotale et al., [21] | 27.6 | 7.3 | 24.3 | 1.6 | 0 | 4 |
| Pal et al., [28] | 43.6 | 38.8 | 18.7 | 6.9 | 7.3 | 10.9 |
| Debdas et al., [24] | 18 | 23 | 48 | 2 | 3 | 6 |
| Mittal et al., [29] | 44.8 | 8.6 | 13.3 | 8.4 | 4.5 | 16.1 |
| Lall et al., [30] | 37.1 | 16.6 | 22.8 | 6 | 4.8 | 13.5 |
MRSA-methicillin resistant Staphylococcus aureus, MSSA- methicillin sensitive Staphylococcus aureus